Rosalind Franklin University Helix 51 Incubator Company BLR Bio Presents Promising New Scleroderma Drug Data at International Rheumatology Meeting

BLR-200 demonstrates unique mechanism blocking activation of scar-forming cells in systemic sclerosis models NORTH CHICAGO, Ill., April 30, 2026 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science announced today that BLR Bio, a company in its Helix 51 incubator,...